RJF

$162.333.25%5.11

Raymond James Financial Inc (RJF)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$157.22

Offen:

$158.06

24-Stunden-Volumen:

857,530

Relatives Volumen:

0.64

Marktkapitalisierung:

$31.23B

Einnahmen:

$16.51B

Nettoeinkommen (Verlust:

$2.15B

KGV:

15.35

EPS:

$10.58

Netto-Cashflow:

$2.22B

1W Leistung:

+2.70%

1M Leistung:

+2.60%

6M Leistung:

+3.92%

1Y Leistung:

+2.31%

1-Tages-Spanne:

$158.06$162.34

1-Wochen-Bereich:

$155.29$161.38

52-Wochen-Spanne:

$138.82$182.73

Raymond James Financial Inc Aktie (RJF) Unternehmensprofil

Firmenname

Raymond James Financial Inc

Sektor

Financial

Branche

Asset Management

Telefon

727-567-1000

Adresse

880 CARILLON PKWY, ST PETERSBURG, FL, USA

Mitarbeiter

24,565

@RaymondJames

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

RJF-Diskussionen auf X

RJF vs. BLK, BX, BN, KKR, BAM vergleichen

Aktien	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RJF Raymond James Financial Inc	$31.23B	$16.99B	$2.31B	$2.22B	$10.58
BLK Blackrock Inc	$180.42B	$27.30B	$6.58B	$3.76B	$40.76
BX Blackstone Inc	$95.86B	$16.11B	$3.52B	$869.79M	$4.46
BN Brookfield Corp	$92.54B	$77.61B	$4.06B	-$8.36B	$0.497
KKR Kroger Co	$87.91B	$21.31B	$3.15B	$8.54B	$2.93
BAM Brookfield Asset Management Ltd	$82.20B	$5.74B	$3.07B	$2.37B	$1.55

Raymond James Financial Inc Aktie (RJF) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-10-02	Eingeleitet	Wells Fargo	Equal Weight
2026-09-01	Eingeleitet	Truist	Hold
2026-01-28	Eingeleitet	Barclays	Overweight
2025-12-11	Resumed	UBS	Neutral
2025-10-03	Eingeleitet	BMO Capital Markets	Market Perform
2025-04-30	Herabstufung	BofA Securities	Buy → Neutral
2025-01-07	Herabstufung	JP Morgan	Overweight → Neutral
2025-01-06	Hochstufung	Goldman	Neutral → Buy
2024-12-12	Herabstufung	Wells Fargo	Overweight → Equal Weight
2024-10-09	Hochstufung	JMP Securities	Mkt Perform → Mkt Outperform
2024-09-12	Eingeleitet	Wells Fargo	Overweight
2024-07-08	Herabstufung	Wolfe Research	Outperform → Peer Perform
2024-01-10	Hochstufung	JP Morgan	Neutral → Overweight
2024-01-09	Herabstufung	Jefferies	Buy → Hold
2024-01-04	Eingeleitet	TD Cowen	Market Perform
2024-01-03	Herabstufung	Goldman	Buy → Neutral
2023-09-19	Eingeleitet	JP Morgan	Neutral
2023-09-11	Eingeleitet	BofA Securities	Buy
2023-07-21	Resumed	Morgan Stanley	Equal-Weight
2022-12-19	Herabstufung	Keefe Bruyette	Outperform → Mkt Perform
2022-11-22	Eingeleitet	UBS	Neutral
2022-10-19	Eingeleitet	Credit Suisse	Neutral
2022-10-12	Eingeleitet	Citigroup	Neutral
2022-01-28	Hochstufung	Seaport Research Partners	Neutral → Buy
2022-01-10	Herabstufung	JMP Securities	Mkt Outperform → Mkt Perform
2021-07-21	Eingeleitet	Jefferies	Buy
2021-01-15	Hochstufung	Wells Fargo	Underweight → Overweight
2021-01-05	Hochstufung	Goldman	Sell → Buy
2021-01-05	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-11-17	Hochstufung	Citigroup	Neutral → Buy
2020-07-08	Eingeleitet	Seaport Global Securities	Neutral
2020-06-09	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-05-18	Herabstufung	Wells Fargo	Equal Weight → Underweight
2020-05-01	Herabstufung	Compass Point	Buy → Neutral
2020-03-25	Hochstufung	Citigroup	Sell → Neutral
2020-03-25	Herabstufung	Wolfe Research	Outperform → Peer Perform
2020-03-24	Herabstufung	Goldman	Neutral → Sell
2020-03-06	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-03-04	Herabstufung	Citigroup	Neutral → Sell
2019-11-20	Eingeleitet	Morgan Stanley	Equal-Weight
2019-03-06	Eingeleitet	Argus	Buy
2018-11-27	Eingeleitet	Goldman	Neutral
2018-10-26	Herabstufung	Citigroup	Buy → Neutral
2018-07-27	Hochstufung	JMP Securities	Mkt Perform → Mkt Outperform
2018-07-13	Hochstufung	Citigroup	Neutral → Buy
2018-05-16	Hochstufung	Goldman	Neutral → Buy
2018-04-27	Hochstufung	Credit Suisse	Underperform → Neutral
2018-04-10	Eingeleitet	Bernstein	Mkt Perform
2018-02-27	Hochstufung	Keefe Bruyette	Mkt Perform → Outperform

Finanzdaten der Raymond James Financial Inc-Aktie (RJF)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Revenue USD (M)	15,912.00	14,923.00	12,992.00	11,308.00	9,910.00
Operating expenses USD (M)	-	-	10,712.00	9,286.00	8,119.00
Operating income USD (M)	-	-	2,280.00	2,022.00	1,791.00
Income before tax USD (M)	-	-	2,280.00	2,022.00	1,791.00
Income tax expense USD (M)	579.00	575.00	541.00	513.00	388.00
Net income USD (M)	2,135.00	2,068.00	1,739.00	1,509.00	1,403.00
Basic EPS USD/shares	10.53	9.94	8.16	7.16	6.81
Diluted EPS USD/shares	10.30	9.70	7.97	6.98	6.63
Basic weighted shares shares (M)	202.00	207.10	211.80	209.90	205.70
Diluted weighted shares shares (M)	206.60	212.30	216.90	215.30	211.20

Raymond James Financial Inc-Aktie (RJF) Insiderhandel

Allaire Bella LoykhterAug 28 '26
Officer
Transaktion
Proposed Sale
Kosten
$177.59
#Aktien
7,500
Wert ($)
1,331,925
#Aktien Gesamt
0
Elwyn Tashtego SJul 28 '26
President, PCG
Transaktion
Sale
Kosten
$176.06
#Aktien
10,000
Wert ($)
1,760,552
#Aktien Gesamt
45,114
Elwyn Tashtego SJul 28 '26
Officer
Transaktion
Proposed Sale
Kosten
$176.06
#Aktien
10,000
Wert ($)
1,760,550
#Aktien Gesamt
0
Raney Steven MJul 27 '26
Executive Chair RJBank
Transaktion
Sale
Kosten
$172.97
#Aktien
5,770
Wert ($)
998,033
#Aktien Gesamt
43,046
Raney Steven MJul 27 '26
Officer
Transaktion
Proposed Sale
Kosten
$172.96
#Aktien
5,770
Wert ($)
997,986
#Aktien Gesamt
0
Allaire Bella LoykhterMar 19 '26
Chief Admin Officer
Transaktion
Sale
Kosten
$142.34
#Aktien
29,551
Wert ($)
4,206,289
#Aktien Gesamt
53,586
Aisenbrey Christopher SFeb 28 '26
Chief Human Resources Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
600
Wert ($)
0
#Aktien Gesamt
17,622
DEBEL MARLENEFeb 19 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,253
Wert ($)
0
#Aktien Gesamt
8,820
Mistarz CecilyFeb 19 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,753
Wert ($)
0
#Aktien Gesamt
4,242
Edwards Jeffrey NFeb 19 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,253
Wert ($)
0
#Aktien Gesamt
11,036

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Allaire Bella Loykhter	Officer	Aug 28 '26	Proposed Sale	$177.59	7,500	1,331,925	0
Elwyn Tashtego S	President, PCG	Jul 28 '26	Sale	$176.06	10,000	1,760,552	45,114
Elwyn Tashtego S	Officer	Jul 28 '26	Proposed Sale	$176.06	10,000	1,760,550	0
Raney Steven M	Executive Chair RJBank	Jul 27 '26	Sale	$172.97	5,770	998,033	43,046
Raney Steven M	Officer	Jul 27 '26	Proposed Sale	$172.96	5,770	997,986	0
Allaire Bella Loykhter	Chief Admin Officer	Mar 19 '26	Sale	$142.34	29,551	4,206,289	53,586
Aisenbrey Christopher S	Chief Human Resources Officer	Feb 28 '26	Option Exercise	$0.00	600	0	17,622
DEBEL MARLENE	Director	Feb 19 '26	Option Exercise	$0.00	1,253	0	8,820
Mistarz Cecily	Director	Feb 19 '26	Option Exercise	$0.00	1,753	0	4,242
Edwards Jeffrey N	Director	Feb 19 '26	Option Exercise	$0.00	1,253	0	11,036

Raymond James Financial Inc Aktie (RJF) Neueste Nachrichten

Oct 30, 2026

Truist cuts Raymond James stock price target to $165 on lower estimates - Investing.com UK

Oct 30, 2026

Oct 29, 2026